These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 4152017)

  • 1. Inhibition of coenzyme Q10-enzymes, succinoxidase and NADH-oxidase, by adriamycin and other quinones having antitumor activity.
    Iwamoto Y; Hansen IL; Porter TH; Folkers K
    Biochem Biophys Res Commun; 1974 Jun; 58(3):633-8. PubMed ID: 4152017
    [No Abstract]   [Full Text] [Related]  

  • 2. Bioenergetics in clinical medicine: prevention by forms of coenzyme Q of the inhibition by adriamycin of coenzyme Q10-enzymes in mitochondria of the myocardium.
    Kishi T; Watanabe T; Folkers K
    Proc Natl Acad Sci U S A; 1976 Dec; 73(12):4653-6. PubMed ID: 1070015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimetabolites of coenzyme Q. 14. Quinolinequinone analogs which inhibit mitochondrial DPNH-oxidase and succinoxidase.
    Bowman CM; Skelton FS; Porter TH; Folkers K
    J Med Chem; 1973 Mar; 16(3):206-9. PubMed ID: 4147386
    [No Abstract]   [Full Text] [Related]  

  • 4. Potential bioreductive alkylating agents. 4. Inhibition of coenzyme Q enzyme systems by lipoidal benzoquinone and naphthoquinone derivatives.
    Lin AJ; Pardini RS; Lillis BJ; Sartorelli AC
    J Med Chem; 1974 Jul; 17(7):688-7. PubMed ID: 4151966
    [No Abstract]   [Full Text] [Related]  

  • 5. Bioenergetics in clinical medicine. III. Inhibition of coenzyme Q10-enzymes by clinically used anti-hypertensive drugs.
    Kishi H; Kishi T; Folkers K
    Res Commun Chem Pathol Pharmacol; 1975 Nov; 12(3):533-40. PubMed ID: 1197930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutual inhibition between NADH oxidase and succinoxidase activities in respiring submitochondrial particles.
    Gutman M; Silman N
    FEBS Lett; 1972 Oct; 26(1):207-10. PubMed ID: 4404628
    [No Abstract]   [Full Text] [Related]  

  • 7. New alkylmercapto-2,3-dimethoxy-1,4-benzoquinones as inhibitors of coenzyme Q systems.
    Vorkapić-Furac J; Kishi T; Kishi H; Porter TH; Folkers K
    Acta Pharm Suec; 1977; 14(2):171-80. PubMed ID: 906834
    [No Abstract]   [Full Text] [Related]  

  • 8. Synthesis and inhibitory activity of new ethylenedioxyquinones as analogs of coenzyme Q.
    Bowman CM; Wikholm RJ; Boler J; Bogentoft CB; Folkers K
    J Med Chem; 1973 Sep; 16(9):988-91. PubMed ID: 4147660
    [No Abstract]   [Full Text] [Related]  

  • 9. Inhibitory effects of several anthracyclines on mitochondrial respiration and coenzyme Q10 protection.
    Solaini G; Ronca G; Bertelli A
    Drugs Exp Clin Res; 1985; 11(8):533-7. PubMed ID: 3869924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and bioassays of a new dimethoxyalkylmercapto-1,4-benzoquinones.
    Wikholm RJ; Iwamoto Y; Bogentoft CB; Porter TH; Folkers K
    J Med Chem; 1974 Aug; 17(8):893-6. PubMed ID: 4152476
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhibition of two human tumor cell lines by antimetabolites of coenzyme Q10.
    Folkers K; Porter TH; Bertino JR; Moroson B
    Res Commun Chem Pathol Pharmacol; 1978 Mar; 19(3):485-90. PubMed ID: 653103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specificity of inhibition of coenzyme Q-enzyme systems by lipoidal benzoquinone derivatives.
    Pardini RS; Catlin JC; Heidker JC; Folkers K
    J Med Chem; 1972 Feb; 15(2):195-7. PubMed ID: 4332674
    [No Abstract]   [Full Text] [Related]  

  • 13. The inhibition of NADH oxidase by the lower homologs of coenzyme Q.
    Lenaz G; Pasquali P; Bertoli E; Parenti-Castelli G
    Arch Biochem Biophys; 1975 Jul; 169(1):217-26. PubMed ID: 1164022
    [No Abstract]   [Full Text] [Related]  

  • 14. Synthesis of new 2,5-bis (1-alkylamino)-1,4-benzoquinones toward antimetabolites of coenzyme Q10 and antitumor agents.
    Porter TH; Kishi T; Folkers K
    Acta Pharm Suec; 1979; 16(1):74-80. PubMed ID: 452911
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhibition of plasma membrane NADH dehydrogenase by adriamycin and related anthracycline antibiotics.
    Sun IL; Crane FL; Löw H; Grebing C
    J Bioenerg Biomembr; 1984 Jun; 16(3):209-21. PubMed ID: 6598803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of adriamycin on respiratory chain activities in mitochondria from rat liver, rat heart and bovine heart. Evidence for a preferential inhibition of complex III and IV.
    Nicolay K; de Kruijff B
    Biochim Biophys Acta; 1987 Jul; 892(3):320-30. PubMed ID: 3036220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimetabolites of coenzyme Q. 20. Synthesis of new alkyl-5,8-quinoxalinequinones as potential inhibitors of coenzyme Q and as antimalarial drugs.
    Porter TH; von Klaudy A; Folkers K
    J Med Chem; 1973 Nov; 16(11):1310-1. PubMed ID: 4147839
    [No Abstract]   [Full Text] [Related]  

  • 18. Direct interaction between mitochondrial succinate-ubiquinone and ubiquinol-cytochrome c oxidoreductases probed by sensitivity to quinone-related inhibitors.
    Yamashita A; Miyoshi H; Hatano T; Iwamura H
    J Biochem; 1996 Aug; 120(2):377-84. PubMed ID: 8889824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effect of endogenous coenzyme Q on both lipid peroxidation and respiratory chain inactivation induced by an adriamycin-iron complex.
    Solaini G; Landi L; Pasquali P; Rossi CA
    Biochem Biophys Res Commun; 1987 Sep; 147(2):572-80. PubMed ID: 3632687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Letter: Prevention by coenzyme Q10 (NSC-140865) of the inhibition by adriamycin (NSC-123127) of coenzyme Q10 enzymes.
    Kishi T; Folkers K
    Cancer Treat Rep; 1976 Mar; 60(3):223-4?U9ENG. PubMed ID: 1260779
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.